BIOMAT Database Logo BIOMAT Database Logo

Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. 2004

J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
University Department of Radiology, Addenbrooke's Hospital, Cambridge, UK.

OBJECTIVE To compare contrast-enhanced MR angiography (CEMRA) with intra-arterial digital subtraction angiography (DSA) for evaluating carotid stenosis. METHODS A total of 167 consecutive symptomatic patients, scheduled for DSA following screening duplex ultrasound (DUS), were prospectively recruited to have CEMRA. Three independent readers reported on each examination in a blinded and random manner. Agreement was assessed using the Bland-Altman method. Diagnostic and potential clinical impact of CEMRA was evaluated, singly and in combination with DUS. RESULTS CEMRA tended to overestimate stenosis by a mean bias ranging from 2.4 to 3.8%. A significant part of the disagreement between CEMRA and DSA was directly caused by interobserver variability. For detection of severe stenosis, CEMRA alone had a sensitivity of 93.0% and specificity of 80.6%, with a diagnostic misclassification rate of 15.0% (n = 30). More importantly, clinical decision-making would, however, have been potentially altered only in 6.0% of cases (n = 12). The combination of concordant DUS and CEMRA reduced diagnostic misclassification rate to 10.1% (n = 19) at the expense of 47 (24.9%) discordant cases needing to proceed to DSA. An intermediate approach of selective DUS review resulted in a marginally worse diagnostic misclassification rate of 11.6% (n = 22) but with only 6.8% of discordant cases (n = 13). CONCLUSIONS DSA remains the gold standard for carotid imaging. The clinical misclassification rate with CEMRA, however, is acceptably low to support its safe use instead of DSA. The appropriateness of combination strategies depends on institutional choice and cost-effectiveness issues.

UI MeSH Term Description Entries
D007089 Image Enhancement Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level. Image Quality Enhancement,Enhancement, Image,Enhancement, Image Quality,Enhancements, Image,Enhancements, Image Quality,Image Enhancements,Image Quality Enhancements,Quality Enhancement, Image,Quality Enhancements, Image
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003951 Diagnostic Errors Incorrect or incomplete diagnoses following clinical or technical diagnostic procedures. Diagnostic Blind Spots,Errors, Diagnostic,Misdiagnosis,Blind Spot, Diagnostic,Blind Spots, Diagnostic,Diagnostic Blind Spot,Diagnostic Error,Error, Diagnostic,Misdiagnoses
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Dose optimization of contrast-enhanced carotid MR angiography.
September 2005, European radiology,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Contrast-enhanced MR angiography of the carotid bifurcation.
September 1999, Journal of magnetic resonance imaging : JMRI,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Contrast-enhanced carotid MR angiography. Imaging principles and physics.
May 1999, Neuroimaging clinics of North America,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Contrast-enhanced MR angiography of the carotid and vertebrobasilar circulations.
September 2005, AJNR. American journal of neuroradiology,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis.
September 2003, Radiology,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
[Clinical use of contrast-enhanced MR angiography].
April 1998, Schweizerische medizinische Wochenschrift,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Clinical utility of contrast-enhanced MR angiography.
January 1997, European radiology,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
The clinical utility of contrast-enhanced 3D MR angiography for cerebrovascular disease.
October 2001, Neurological research,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Contrast-enhanced MR angiography.
January 1999, Radiologic technology,
J M U-King-Im, and R A Trivedi, and M J Graves, and N J Higgins, and J J Cross, and B D Tom, and W Hollingworth, and H Eales, and E A Warburton, and P J Kirkpatrick, and N M Antoun, and J H Gillard
Contrast-enhanced MR angiography.
January 1998, Abdominal imaging,
Copied contents to your clipboard!